Prothena
在场
高管
查看带有其 20 名主要高管的组织结构图
Prothena 搜索最多的简介
- Gene Kinney, President, Chief Executive Officer and Director
- Oleg Nodelman, Director
- Billy Dunn, Director
高管在Prothena变化
- Chad Swanson 曾任 Senior Vice President and Head of Clinical Development and Explorations, 现升职为 Chief Development Officer (新闻发布的2024九月30号).
- David Ford已作为Chief People Officer加入公司 (新闻发布的2024三月5号).
创建提醒
跟踪 Prothena 的高管变动
生物技术
Prothena 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Prothena 的最新新闻稿
- Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease | Prothena Corporation plc
- RSS NEWS FEEDS | Prothena Corporation plc
- Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Prothena Corporation plc
- Prothena to Hold Investor Webcast to Discuss Results from Phase 2 PASADENA Study Presented at the International Parkinson and Movement Disorder Society's MDS Virtual Congress | Prothena Corporation plc
- Prasinezumab Slows Progression on Measures of Parkinson’s Disease in Phase 2 Study | Prothena Corporation plc
- Prothena to Present at the 2020 Cantor Virtual Global Healthcare Conference on September 15 | Prothena Corporation plc
- Prothena Announces Updated Timing of Presentation for Phase 2 PASADENA Study Results at International Congress of Parkinson’s Disease and Movement Disorders | Prothena Corporation plc
- Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Prothena Corporation plc
- Prothena Reports Second Quarter 2020 Financial Results and Provides R&D Update | Prothena Corporation plc
- Prothena Announces Phase 2 PASADENA Study Results to be Presented at International Congress of Parkinson’s Disease and Movement Disorders | Prothena Corporation plc
- View more press releases Close
通过电子邮件
